168 results
Page 2 of 9
8-K
EX-99.1
pfgp4t9 11j
10 Mar 22
Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials
4:20pm
8-K
EX-99.1
jtosk
3 Nov 21
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
4:11pm
8-K
EX-99.1
cmtexkv
23 Aug 21
Other Events
4:43pm
8-K
EX-99.1
zr9zj ior88nl6gjgs
5 Aug 21
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:27pm
8-K
EX-99.1
r6lrx6e9pdp 94e
21 Jul 21
Lumos Pharma Announces Clinical Updates
8:33am
8-K
EX-99.1
pln81l4d
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.1
eayyykyoy79a1dzst
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
EX-10.1
69y6q
30 Dec 20
Entry into a Material Definitive Agreement
4:44pm
424B5
3tsp1533j1lhmo0 2e
30 Dec 20
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.1
bgie3shst3wx w8z
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
EX-99.1
8nol2f28b89fp3g3o
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm